Global Lyme Alliance attends HHS roundtable on Lyme disease, discussing patient care, diagnostics, and research advancements with key stakeholders. On December 15, the U.S. Department of Health and Hu...
On December 15th, GLA will participate in the HHS National Lyme Disease Roundtable to discuss advancing care and policy for Lyme disease and related chronic conditions. The U.S. Department of Health a...
We are heartbroken by the sudden passing of Dr. Amiram Katz, MD, DABPN— a brilliant neurologist, innovator, and deeply compassionate physician.
Based on research conducted at UMass Medical School, TNX-4800 is a long-acting monoclonal antibody now being licensed to Tonix Pharmaceuticals for further development as single-dose, seasonal protecti...
GLA’s Chief Scientific Officer featured on BBC’s The Inquiry podcast, discussing global rise in Lyme disease and new developments in the field. Global Lyme Alliance’s Chief Scientific Officer, Dr. Arm...